NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TidalSense

TidalSense

Private
CambridgeHealthcare & Life Scienceshttps://tidalsense.com/

Last Round

Grant

Feb 6, 2025

Total Funding Raised

$3.43M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TidalSense is a healthcare technology company that develops AI-driven respiratory diagnostic and monitoring tools capable of detecting changes in lung function through real-time conversion of sensor data into respiratory biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sensors

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware + Subscription

AI Layer

Application

Keywords

medical AICOPD diagnosisrespiratory diagnosticsmedtechpoint-of-care testingdigital healthAI diagnosticsmedical deviceAI-driven diagnosticshealth IoTsmart sensorusage-based billingclinical decision supportremote patient monitoringdigital biomarker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TidalSense Comps

Public and private peers based on sector, stage, and business model.

TidalSense comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TidalSense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 6, 2025
VC RoundMay 16, 2023
SeedApr 13, 2023
GrantJan 4, 2023
VC RoundDec 1, 2020
Grant
Nov 1, 2016

Key People

Founding team and executive leadership

Christian Faires CGMA ACMA

Chief Financial Officer

Executive Team

TidalSense Investors

Notable investors and investment history

TidalSense investors
InvestorRounds
Foresight Group Holdings LimitedSeed
SBRI HealthcareGrant
BGFVC Round
DowningVC Round
Innovate UKGrant
Downing VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Launched AI-driven diagnostic test for COPD using patented sensor technology.

  • Feb 3, 2026

    Seeking regulatory clearance for medical devices in USA, EU, Canada, and China.

TidalSense Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TidalSense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TidalSense's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range32
Year Founded2013
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.